June 24, 2020 GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug Continue reading →
May 15, 2020 MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos Continue reading →
May 6, 2020 Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21 Continue reading →